Updates ·
Health notices · Saturday 26 September
3 notices from the agencies today, in plain words, each with the original linked.
FDA approved Synjardy for type 2 diabetes treatment
Food and Drug Administration (FDA) · Approval
If you have type 2 diabetes, the FDA has approved Synjardy (and Synjardy XR) to be used with diet and exercise to improve glycemic control (blood sugar levels).
Synjardy combines empagliflozin, an SGLT2 inhibitor (helps lower blood sugar by affecting the kidneys), with metformin. For adults, empagliflozin is also indicated to reduce certain risks related to heart and kidney disease.
Your prescription may need to change only if your clinician decides Synjardy/Synjardy XR is appropriate for you. This approval is for specific types of diabetes and age groups described in the label.
Acetylcysteine solution contaminated with particulate matter
FDA · Recall
The FDA has issued a Class II recall for acetylcysteine solution, USP 20% (200 mg/mL) that is packaged as a 4 mL vial or multiple 4 mL vials. The product is marked NOT FOR INJECTION.
This recall is because contaminated particles were found, including hair, glass, and/or paraformaldehyde.
If you have this product, follow the recall instructions provided with the notice. If you are unsure, use the contacting information in the recall materials to confirm what to do next.
Ebola outbreak in DR Congo expands to two more health zones
World Health Organization (WHO) · Outbreak
If you live in or travel to parts of the Democratic Republic of the Congo affected by Bundibugyo virus Ebola, the situation has worsened. Two additional health zones have been affected since the last WHO outbreak update.
As of 23 September 2026, WHO reports 7,890 confirmed cases and 3,799 deaths in the country. WHO says daily new cases remain high and that delays in early detection and care are ongoing.
New affected areas increase the risk of cross-border transmission. Serious illness and deaths continue, including deaths occurring in communities, households, and healthcare settings.